Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SCN2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PSMG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF418 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
YY1AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-F-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERTAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF507 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on